Cardiac amyloidosis masked by anchoring bias in a patient with repaired atrial septal defect: a case report
Year: 2026
Type: preprint
Study design: Case Report
Abstract: Background: Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy that frequently mimics other cardiac conditions and is easily overlooked once a structural cardiac diagnosis has been established. We report a case of systemic lambda light-chain (AL) amyloidosis unmasked four years after surgical repair of an atrial septal defect (ASD), highlighting the diagnostic anchoring bias that delayed recognition. Case presentation: A 75-year-old woman presented with refractory heart failure four years after surgical repair of an ASD. Her progressively worsening symptoms had been attributed solely to the pre-existing structural heart disease. On readmission, transthoracic echocardiography demonstrated biatrial enlargement, severe mitral and tricuspid regurgitation, biventricular wall thickening with a granular sparkling appearance, and a small pericardial effusion. Three-dimensional speckle-tracking echocardiography revealed profoundly reduced left ventricular global longitudinal strain (GLS, -6.0%) with relative apical sparing, and reduced right ventricular free-wall longitudinal strain (-8.1%). Electrocardiography showed atrial fibrillation, intraventricular conduction delay, and poor precordial R-wave progression. Serum immunofixation electrophoresis detected a lambda-type monoclonal protein, with a markedly elevated free lambda light chain and a decreased kappa/lambda ratio. Abdominal fat pad biopsy showed Congo red-positive amyloid deposits, and electron microscopy revealed rigid, non-branching amyloid fibrils measuring 8-12 nm in diameter, confirming systemic AL amyloidosis. According to the revised Mayo 2012 staging system (NT-proBNP 29,218 pg/mL), she was classified as stage III. The patient declined bone marrow biopsy and clone-directed chemotherapy and was transferred to another hospital for further management. Conclusions: Once a structural cardiac diagnosis is established, clinicians are prone to anchoring bias and may overlook coexisting infiltrative disease. In patients with refractory or progressive heart failure after correction of structural heart disease, systematic reassessment-including strain echocardiography, monoclonal protein screening, and tissue biopsy-should be pursued to unmask CA and enable timely, potentially life-prolonging therapy.
Source: Research Square
Institution: Wuhan Asia Heart Hospital
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7235125504
